Home Biosimilar Antibodies Immunology & Inflammation CD markers antibody Ligufalimab (Anti-CD47) For research use only.
Not for use in humans.

Ligufalimab (Anti-CD47)

Synonyms: AK 117

Ligufalimab (Anti-CD47) is a humanized immunoglobulin G4 (IgG4) monoclonal antibody targeting leukocyte surface antigen CD47, with potential immune checkpoint inhibitory and antineoplastic activities. MW : 144.58 KD.

Ligufalimab (Anti-CD47)

Purity & Quality Control

Batch: A282501 Purity: 99% Protein concentration: 8.58mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective CD markers Inhibitors

Biological Activity

Description Ligufalimab (Anti-CD47) is a humanized immunoglobulin G4 (IgG4) monoclonal antibody targeting leukocyte surface antigen CD47, with potential immune checkpoint inhibitory and antineoplastic activities. MW : 144.58 KD.

Product Details

CAS No. 2428381-55-7
Molecular Weight 144.58
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Ligufalimab (Anti-CD47) | Ligufalimab (Anti-CD47) supplier | purchase Ligufalimab (Anti-CD47) | Ligufalimab (Anti-CD47) cost | Ligufalimab (Anti-CD47) manufacturer | order Ligufalimab (Anti-CD47) | Ligufalimab (Anti-CD47) distributor